Lysine

Lysine

SCHEMBL302610

C[C@H](N)C(=O)O.NCCCC[C@H](N)C(=O)O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.83
ARG2 P78540 4/20 0.52
ARG1 P05089 3/20 0.52
NOS2 P35228 6/20 0.50
NOS1 P29475 4/20 0.50
NOS3 P29474 3/20 0.50
CYP1A2 P05177 2/20 0.50
TSHR P16473 2/20 0.50
RNPEP Q9H4A4 1/20 0.50
CYP3A4 P08684 1/20 0.50
BLM P54132 1/20 0.49
CYP2C19 P33261 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CPB2 Q96IY4 1/20 0.46
GLA P06280 1/20 0.46
NFKB1 P19838 1/20 0.46
APEX1 P27695 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL6538526 1.00 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL15753994 1.00 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL19742881 1.00 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL1433568 1.00 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL5581427 1.00 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL301792 1.00 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL28318609 1.00 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL1696587 1.00 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL7861429 1.00 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL9448118 0.98 GSR (0.80) GSRARG2ARG1NOS2NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023172648-A2 FLUOROGENIC SUBSTRATES FOR AMINOPEPTIDASE DETECTION IN BIOFLUIDS GLYMPSE BIO, INC. (US) 2023-09-14 WO claimed
WO-2023140197-A1 MODIFIED RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BINDING PROTEIN AND METHOD OF ANALYSIS OF AAV BASED ON INFECTION ABILITY 東ソー株式会社 2023-07-27 WO claimed
CN-115990265-A Polymer-drug conjugate capable of targeting tumor cell endoplasmic reticulum 四川大学 2023-04-21 CN claimed
CN-113195487-A 2, 3-diaminosuccinyl conjugate linkers 杭州多禧生物科技有限公司 2021-07-30 CN claimed
EP-3818062-A1 CROSS-LINKED PYRROLOBENZODIAZEPINE DIMER (PBD) DERIVATIVE AND ITS CONJUGATES Hangzhou Dac Biotech Co., Ltd (CN) 2021-05-12 EP claimed
CN-112272669-A Cross-linked pyrrolobenzodiazepine dimer (PBD) derivatives and conjugates thereof 杭州多禧生物科技有限公司 2021-01-26 CN claimed
EP-3606922-A1 CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE Hangzhou Dac Biotech Co., Ltd (CN) 2020-02-12 EP claimed
WO-2020006722-A1 CROSS-LINKED PYRROLOBENZODIAZEPINE DIMER (PBD) DERIVATIVE AND ITS CONJUGATES HANGZHOU DAC BIOTECH CO., LTD (CN) 2020-01-09 WO claimed
CN-110621673-A Double-stranded linked cytotoxic drug conjugates 杭州多禧生物科技有限公司 2019-12-27 CN claimed
WO-2018185526-A1 CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE HANGZHOU DAC BIOTECH CO., LTD (CN) 2018-10-11 WO claimed
EP-1907843-B1 UNIFORMLY CONJUGATED SERINE HYDROLASES ISRAEL STATE (IL) 2013-11-27 EP claimed
WO-2013077886-A2 PROTEASE DEGRADABLE POLYPEPTIDES AND USES THEREOF THE METHODIST HOSPITAL SYSTEM (US) 2013-05-30 WO claimed
US-8227251-B2 Mass spectrum-based identification and quantitation of proteins and peptides INSTITUTE FOR SYSTEMS BIOLOGY (US) 2012-07-24 US claimed
WO-2012004380-A1 DIAGNOSIS, PROPHYLAXIS AND THERAPY OF ALZHEIMER'S DISEASE AND OTHER NEURODEMENTING DISORDERS BALAKRISHNAN KARTHIKEYAN (DE) 2012-01-12 WO claimed
EP-2404612-A1 Diagnosis, prophylaxis and therapy of Alzheimer's disease and other neurodementing disorders Balakrishnan, Karthikeyan (DE) 2012-01-11 EP claimed
WO-2010120946-A1 IMPROVEMENTS IN MASS SPECTRUM-BASED IDENTIFICATION AND QUANTITATION OF PROTEINS AND PEPTIDES INSTITUTE FOR SYSTEMS BIOLOGY (US) 2010-10-21 WO claimed
US-20100261279-A1 MASS SPECTRUM-BASED IDENTIFICATION AND QUANTITATION OF PROTEINS AND PEPTIDES INSTITUTE FOR SYSTEMS BIOLOGY 2010-10-14 US claimed
EP-1944314-A1 Diagnosis of Alzheimer's disease and other neurodementing disorders Philipps-Universität Marburg (DE) 2008-07-16 EP claimed
WO-2026077418-A9 ISOINDOLINE COMPOUND CONTAINING PHENYLETHOXYALKYLENEAMINE STRUCTURE, CONJUGATE THEREOF, AND USE THEREOF 上海海雁医药科技有限公司 2026-05-15 WO disclosed
EP-0069678-A2 3-Fucosyl-N-acetyl-lactosamine derivatives, their preparation and their biological applications CHOAY S.A. (FR) 1983-01-12 EP disclosed